Navigation Links
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex
Date:5/13/2010

The joint venture Abbymex is announced by Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. to provide a consistent supply of logwood extract used in the production of hematoxylin and hematine. Hematoxylin is a key ingredient in stains used by biological laboratories for Pap smear tests and hematine is used to dye medical sutures. Abbey Color is the world’s largest manufacturer of both hematoxylin and hematine.

Philadelphia, PA (PRWEB) May 13, 2010 -- Abbey Color Inc., located in Philadelphia, Pennsylvania, USA, announces a joint venture with Mexicana de Extractos International, S.A. de C.V., located in Campeche, Mexico. Mexicana de Extractos has supplied logwood extract to Abbey Color Inc. for their Hematoxylin and Hematine production for over thirty years and the newly formed joint venture, registered as Abbymex, is being built on the strong foundation of mutual respect and trust that has evolved over the years because of the high principles espoused by both companies.

“We are very excited about this venture,” explained Roger Nielsen, President and Owner of Abbey Color Inc. “This investment continues our strategic plan to meet the critical need for Hematoxylin and Hematine in the health industry worldwide. This is a responsibility we take very seriously, and we have demonstrated our commitment through our substantial investment in this joint venture. We are pleased to partner with Mexicana de Extractos, a company of excellent reputation and one which shares our values and our vision. As a result of this venture, our customers throughout the world can purchase their materials, confident in the knowledge that problems with periodic shortages will now be a thing of the past. In accordance with the integrity principles of our combined companies, we have also resolved to maintain a consistent and reasonable pricing structure, as we have done in the past.”

This venture signifies both parties’ dedication to continue supplying hematoxylin to the Hemotoxylin and Eosin Y (H&E) stain markets in North America and throughout the world. Agreements within the formulation of the Abbymex joint venture will ensure continuous and consistent supply of logwood extract to the Abbey Color facility in Philadelphia as to maintain uninterrupted production and inventory building of hematoxylin and hematine.

About Abbey Color Inc.
Abbey Color is a premier dye manufacturer and supplier of industrial dyes, dye precursors and colorants serving various domestic and international markets ranging from healing practices to industrial uses. Abbey Color is the world’s leading manufacturer of hematoxylin and is the only dye manufacturer in the world that makes both hematoxylin and eosin Y. Abbey Color is a supplier to the makers of various biological stain products and hematoxylin is always in stock. Abbey Color's hematoxylin is certified by the Biological Stain Commission (BSC). Hematoxylin is the key ingredient in stains used by biological laboratories and pathologists for Pap smear tests using H&E stain and other procedures. Hematine is used for the dyeing of silk that is used in medical sutures. Abbey Color is a ChemStewards® certified facility.

Contact Abbey Color
For more information or to inquire about Abbey Color’s products and services, including hematoxylin, hematine, logwood extract and biological stain products, please call 215-739-9960 or visit the Abbey Color website at www.AbbeyColor.com.

###

Read the full story at http://www.prweb.com/releases/abbymex/joint-venture/prweb3995624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Exploring gender differences in colorectal cancer screenings
2. Homewatch CareGivers Show in Colorado is Next for SilverStone Group's In-Home Care Team
3. Plastics Color Corporation Expands Into California
4. Three Genes Linked to Variations in Eye Color
5. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
6. Investigators examine colorectal cancer screening methods among diverse populations
7. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
8. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Hispanics live in areas with limited capacity for colorectal cancer screening
11. Leukemia-related protein 16 and colorectal carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex 
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin ... one of few medical professionals in the country to sit on the 2017 National ... Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... offered by the American Association of Integrative Medicine and available for application on ... at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work ... a variety of business channels. , While many results are clear, much of PR ... program. , When it comes to measurement, firms should always take an all-inclusive ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of its ... in Marshallville in 2006, and a bagging and shipping facility has been in place ... Seed operations to the Middle Georgia location from their previous home in Lakeland, Georgia. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... to reach a value of USD 4.5 billion by ... Research, Inc. Proper closure of injured tissues post operation ... function. Postoperative leakages occur in 3% to 15% of ... are responsible for one third of postoperative deaths in ...
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
(Date:3/27/2017)... March 27, 2017 Summary ... understand Eli Lilly and its partnering interests and activities since ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ... data. The report will be delivered in PDF ...
Breaking Medicine Technology: